HanchorBio Prices Taiwan IPO at NT$120 Amid Rising Global Demand for Immunotherapy Innovation
HanchorBio, Inc. has priced its initial public offering at NT$120 per share ahead of its scheduled May 29 listing on Taiwan’s Innovation Board, marking one of the latest signs that…
